9 Meters Biopharma, Inc. Research and Development Expense
9 Meters Biopharma, Inc. reported Research and Development Expense of $2.60 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2020-05-15
- 9 Meters Biopharma, Inc. research and development expense for the quarter ending 2020-03-31 was $2.60M, a 116.89% increase year-over-year.
- 9 Meters Biopharma, Inc. research and development expense for the quarter ending 2019-12-31 was $5.50M, a 215.51% increase year-over-year.
- 9 Meters Biopharma, Inc. research and development expense for the quarter ending 2019-09-30 was $3.94M.
- 9 Meters Biopharma, Inc. research and development expense for the quarter ending 2019-06-30 was $3.07M, a 147.21% increase year-over-year.
- 9 Meters Biopharma, Inc. research and development expense for fiscal 2019 was $13.72M, a 81.45% increase from fiscal 2018.
- 9 Meters Biopharma, Inc. research and development expense for fiscal 2018 was $7.56M, a 88.60% increase from fiscal 2017.
- 9 Meters Biopharma, Inc. research and development expense for fiscal 2017 was $4.01M, a 1384.41% increase from fiscal 2016.
- 9 Meters Biopharma, Inc. research and development expense for fiscal 2016 was $270.00K, a 18.92% decline from fiscal 2015.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-03-31 | $2.60M 10-Q · filed 2020-05-15 | $8.10M derived: sum of 2 quarters · filed 2020-05-15 | $12.04M derived: sum of 3 quarters · filed 2020-05-15 | $15.12M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2019-12-31 | $5.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $9.44M derived: sum of 2 quarters · filed 2020-03-20 | $12.52M derived: sum of 3 quarters · filed 2020-03-20 | $13.72M 10-K · filed 2020-03-20 | ||||
| 2019-09-30 | $3.94M 10-Q · filed 2019-11-07 | $7.02M derived: sum of 2 quarters · filed 2019-11-07 | $8.22M 10-Q · filed 2019-11-07 | $9.96M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2019-06-30 | $3.07M 10-Q · filed 2019-08-08 | $4.27M 10-Q · filed 2019-08-08 | $6.02M derived: sum of 3 quarters · filed 2020-05-15 | $4.23M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2019-03-31 | $1.20M 10-Q · filed 2020-05-15 | $2.94M derived: sum of 2 quarters · filed 2020-05-15 | $1.16M derived: sum of 3 quarters · filed 2020-05-15 | $2.40M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$42.15K derived: sum of 2 quarters · filed 2020-03-20 | $1.20M derived: sum of 3 quarters · filed 2020-03-20 | $7.56M 10-K · filed 2020-03-20 | ||||
| 2018-09-30 | -$1.79M 10-Q · filed 2019-11-07 | -$542.42K derived: sum of 2 quarters · filed 2019-11-07 | $5.82M 10-Q · filed 2019-11-07 | $6.99M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $1.24M 10-Q · filed 2019-08-08 | $7.60M 10-Q · filed 2019-08-08 | $8.78M derived: sum of 3 quarters · filed 2019-08-08 | $9.14M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $6.36M 10-Q · filed 2019-05-10 | $7.53M derived: sum of 2 quarters · filed 2019-05-10 | $7.90M derived: sum of 3 quarters · filed 2019-05-10 | $9.03M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.54M derived: sum of 2 quarters · filed 2019-03-18 | $2.67M derived: sum of 3 quarters · filed 2019-03-18 | $4.01M 10-K · filed 2019-03-18 | $190.00K 10-K · filed 2018-03-14 | |||
| 2017-09-30 | $367.55K 10-Q · filed 2018-11-13 | $19.00K 10-Q · filed 2017-11-08 | $1.50M derived: sum of 2 quarters · filed 2018-11-13 | $2.83M 10-Q · filed 2018-11-13 | $170.00K 10-Q · filed 2017-11-08 | $2.93M derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | $1.13M 10-Q · filed 2018-08-14 | $81.00K 10-Q · filed 2017-08-21 | $2.47M 10-Q · filed 2018-08-14 | $150.00K 10-Q · filed 2017-08-21 | $2.57M derived: sum of 3 quarters · filed 2018-08-14 | $2.62M derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2017-03-31 | $1.34M 10-Q · filed 2018-05-15 | $70.00K 10-Q · filed 2017-05-19 | $1.44M derived: sum of 2 quarters · filed 2018-05-15 | $1.49M derived: sum of 3 quarters · filed 2018-05-15 | $1.56M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $156.00K derived: sum of 2 quarters · filed 2018-03-14 | $221.00K derived: sum of 3 quarters · filed 2018-03-14 | $270.00K 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | $54.00K 10-Q · filed 2017-11-08 | $119.00K derived: sum of 2 quarters · filed 2017-11-08 | $168.00K 10-Q · filed 2017-11-08 | $213.00K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $65.00K 10-Q · filed 2017-08-21 | $114.00K 10-Q · filed 2017-08-21 | $159.00K derived: sum of 3 quarters · filed 2017-08-21 | $257.00K derived: sum of 4 quarters · filed 2017-08-21 | ||||
| 2016-03-31 | $49.00K 10-Q · filed 2017-05-19 | $94.00K derived: sum of 2 quarters · filed 2017-05-19 | $192.00K derived: sum of 3 quarters · filed 2017-05-19 | $311.00K derived: sum of 4 quarters · filed 2017-05-19 | ||||
| 2015-12-31 | $45.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $143.00K derived: sum of 2 quarters · filed 2017-03-31 | $262.00K derived: sum of 3 quarters · filed 2017-03-31 | $333.00K 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | $98.00K 10-Q · filed 2016-11-16 | $217.00K derived: sum of 2 quarters · filed 2016-11-16 | $288.00K 10-Q · filed 2016-11-16 | |||||
| 2015-06-30 | $119.00K 10-Q · filed 2016-08-15 | $246.00K 10-Q · filed 2016-08-15 |